Covaxin shot recommended for children in India

• An expert panel on Tuesday recommended the use of Covaxin, developed by the Bharat Biotech, for inoculating children between 2 and 18 years.

• Bharat Biotech had submitted the results data from clinical trials in the two - 18 age group for Covaxin to CDSCO (Central Drugs Standard Control Organisation). This data was then reviewed by the Subject Expert Committee (SEC).

• Junior Union Health Minister Dr Bharti Pravin Pawar stated that the government had committed that it will bring a vaccine for children soon. The SEC has recommended it and it is will be approved soon. The final approval has to be come from Drug Controller General of India.

• Another potential vaccine for kids is Serum Institute's Novavax, for which the DCGI last month cleared trials for children between seven and 11 years.